littl inform thesi overal top line ex-
comps/one-tim slowest year margin remain
chang view result quarter modestli weaker
top line expect consid easi comp though non-gaap
margin less headwind notabl consid advers mix
impli persist outgrowth medical/vet see exhibit though still
sourc pressur medic vet segment see moder growth
medic deceler comp-adjust basi anim health
deceler comp-adjust see exhibit dental growth stronger
fear given mute growth dhr/mmm rel check
privat player space observ weaker year-end equip dynam
detail see exhibit detail analysi quarter confound
variat sell day year year given extra week prior year
ftc-relat commentari reiter engag buy group
reiter prior commentari compani long engag
buy group view complaint meritless see new ftc lawsuit
alleg coordin chang rel current price polici anticip
gpo contact expect ftc case impact pricing/engag polici
gpo benefit estim gpo aggreg buy power
independ practic one form buy group discuss
ftc repres us dental market today in-lin revenu
exposur state dental associ purchas group texa arizona
california gain limit traction date could repres
increment risk market price could larg dso gpo
combin given activ state organ repres least dentist
individu size could dwarf dso regardless outcom
suit view unsustain dental distributor margin
acceler buy group price pressur consolid acceler
outsid entrant remain unchang remain underweight
downgrad underweight
highlight call estim sirona cadcam equip
contribut quarter na dental equip
growth quarter overal na dental growth would
medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
impli increment growth estim comp-
adjust growth acceler rais guidanc
driven tax rate prior absorb headwind
one-tim bonu pay-out updat guidanc impli chang
drive efficiency/product gain cost save expect
materi chang field forc number quantifi potenti impact
 a/margin growth outlook impli na dental consum
market grow vs trail five-year compound-annual-growth-rate though continu
gain market share expect grow na dental consum vs
estim dental consum growth step
due weak germany/france/itali continu theme see
price margin tougher dilig manufactur suggest
e-commerce competit step eu manag expect
improv intern dental revenu medium term strong na
dental equip drove servic revenu growth quarter offset weaker
softwar growth medic normal market growth share gain
increment difficult manag expect sell flu vaccin
dose in-lin
nomin model/valu chang lower revenu forecast
rais ebit margin organ basi model
ebit margin expans vs trend closer potenti gener
approach given organ ebit margin last
quarter overal net chang ep forecast remain
consensu ep spite assumpt improv margin
trend pt base target yield estim
target yield high-end coverag given slower
growth per share compound-annual-growth-rate vs broader coverag
pt impli price-to-earnings multipl ntm multipl
risk reward market leader tough market
risk reward market leader tough market
bull case ep
bull case ep
organ growth acceler driven greater expect share gain
dental busi margin improv faster expect tax reform
drive corpor tax rate multipl expand back
base case ep
base case ep
pt base yield estim forecast
dental busi organ growth rang anim health
rang medic rang combin normal organ
growth margin remain pressur on-going custom consolid e-
commerc competit creat price/mix headwind impli multipl
compress price-to-earnings current price-to-earnings ntm ep
global distributor dental
anim health medic product
fragment consolid custom base
independ corpor practic
expect continu outgrow
end market gain share
dental product categori cerec
consum open north
american sirona distribut
appreci market market
adequ appreci structur
pressur price margin
risk
open north american dental
equip distribut drive
near-term sale acceler organ
growth
due gross margin compress
custom
consolid price supplier
consolid cog
bear case ep
bear case ep
competit heat distributor amzn/discount e-commerc
player aggress cut price basic na dental
consum na dental na medic consum segment
mix companion anim pharma product mix drive global
dental sale margin contract significantli due fix cost
de-lever multipl move toward histor recessionari trough in-lin
introduct clear align product
expans medic segment
entri product anim market
risk achiev price
outpati medic dental util
slow medicaid coverag pullback
impact discretionari spend dental
companion anim
capit deploy new high margin
on-line competit enter market
slower expect
guidanc
guidanc
msd growth
impact
exhibit chang forecast
sale
sale
sale
sale
sale
sale
million except ep
incom exp
compani data morgan stanley research
valuat risk
morgan stanley research thomson reuter
morgan stanley research thomson reuter
morgan stanley research thomson reuter
morgan stanley research thomson reuter
pt base yield estim forecast dental
busi organ growth rang anim health rang medic
rang combin normal organ growth margin remain
pressur on-going custom consolid e-commerc competit creat
price/mix headwind impli multipl compress price-to-earnings current
price-to-earnings ntm ep
dental companion anim outpati medic dental util slow
healthcar coverag pullback on-line competit enter market earlier
expect creat larger expect headwind price/mix
incom expens
incom tax
equiti earn affili
incom noncontrol
net continu op
revenu
restructur
net incom continu op
ep continu oper
acquisit impact
acquisit impact
acquisit impact
acquisit impact
technolog value-ad servic
acquisit impact
acquisit impact
